Early stop of progesterone supplementation after confirmation of pregnancy in IVF/ICSI fresh embryo transfer cycles of poor responders does not affect pregnancy outcome
Journal
PLoS ONE
Journal Volume
13
Journal Issue
8
Pages
e0201824
Date Issued
2018
Author(s)
Abstract
Previous studies indicated that progesterone can be withdrawn at the time of the first positive β-hCG test without compromising the clinical pregnancy outcome in normal ovarian responder. However, the effect of early stop of progesterone supplementation for patients with poor ovarian response (POR) has not been investigated. This study retrospectively collected data from patients with POR in 156 IVF/ICSI fresh embryo transfer (ET) cycles in single tertiary center from January 2010 to June 2016. All the patients met ESHRE consensus, the Bologna criteria, of POR and had hCG injection for luteal phase support (LPS) on day 2, 5 and 8 after ovum pick-up. The pregnant patients were divided into two groups: early stop group represented those who stopped LPS from day of positive pregnancy test; control group represented those who kept progesterone supplementation till gestational age of 9 weeks. There were no significant differences in age, BMI, parity, hormone data, number of follicles>10(mm), endometrial thickness and number of embryos transferred between the two groups. After adjustment for possible confounders with multivariate logistic regression analysis, the clinical pregnancy rates (55.0% vs. 57.1%, P = 0.35), ongoing pregnancy rates (47.0% vs. 46.4%, P = 0.66), miscarriage rates (34.0% vs. 26.7%, P = 0.66) and live-birth rates (44.0% vs. 46.4%, P = 0.41) were not statistically different between early stop group and the control group. Our study indicates that early stop of progesterone supplementation on the day of positive pregnancy test for patients of POR using hCG as LPS in fresh ET cycles does not affect pregnancy outcome. ? 2018 Pan et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
SDGs
Other Subjects
chorionic gonadotropin; estradiol; follitropin; luteinizing hormone; progesterone; gestagen; progesterone; adult; age; Article; body mass; controlled study; embryo transfer; endometrial thickness; estradiol blood level; female; follitropin blood level; gestational age; human; human cell; in vitro fertilization; intracytoplasmic sperm injection; live birth; luteal phase; luteinizing hormone blood level; major clinical study; multivariate logistic regression analysis; oocyte; ovary follicle; parity; pregnancy outcome; pregnancy rate; progesterone blood level; retrospective study; spontaneous abortion; supplementation; tertiary health care; middle aged; pregnancy; pregnancy test; procedures; time factor; Adult; Embryo Transfer; Female; Fertilization in Vitro; Humans; Middle Aged; Pregnancy; Pregnancy Outcome; Pregnancy Tests; Progesterone; Progestins; Retrospective Studies; Time Factors
Publisher
Public Library of Science
Type
journal article